APO866 activity in hematologic malignancies: a preclinical in vitro study

Blood. 2009 Jun 4;113(23):6035-7; author reply 6037-8. doi: 10.1182/blood-2009-03-209213.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamides / therapeutic use*
  • Acrylamides / toxicity
  • Apoptosis / drug effects
  • Drug Evaluation, Preclinical
  • Hematologic Neoplasms / drug therapy*
  • Humans
  • Piperidines / therapeutic use*
  • Piperidines / toxicity

Substances

  • Acrylamides
  • N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
  • Piperidines